Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd. (Nasdaq: AFJK) is a blank check company that completed its initial public offering in 2023 with a stated focus on identifying acquisition targets in the health technology sector. The SPAC filed a Form 10-Q with the Securities and Exchange Commission on August 9, 2024, covering its financial position as it continues to pursue a qualifying business combination. Aimei Health Technology is oriented toward healthcare and technology-driven targets, reflecting broader SPAC interest in companies operating at the convergence of digital health and life sciences. For full filings, sponsor details, deal timelines, and search-status data on AFJK, sign up for complete access at SpacDesk.